Trials / Terminated
TerminatedNCT00164788
A Comparison of Gastric pH Control With High Dose Intravenous or Oral Esomeprazole
A Randomized Comparison of High Dose Oral to Intravenous Esomeprazole in Patients After Endoscopic Control to Their Bleeding Peptic Ulcers: an Intra-gastric pH Study.
- Status
- Terminated
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 7 (actual)
- Sponsor
- Chinese University of Hong Kong · Academic / Other
- Sex
- All
- Age
- 18 Years – 80 Years
- Healthy volunteers
- Not accepted
Summary
The investigators hypothesize that high dose esomeprazole 80mg given as a bolus, followed by 8mg/h would render gastric pH near neutral and that pH control with esomeprazole given in such a high dose either intravenous or orally is identical.
Detailed description
Bleeding peptic ulcer is a common and life threatening condition. Endoscopic therapy has become the mainstay of controlling bleeding. Recurrent bleeding after endoscopic control occurs in about 20% of patients with a high associated mortality. We previously demonstrated that the adjunct use of high dose proton pump inhibitor reduces risk of recurrent bleeding and thereby improves patients' outcome \[Lau JY N Engl J Med 2000\]. The newer PPI, esomeprazole, is an S-isomer of omeprazole. Esomeprazole is more effective in gastric acid control as measured by both basal and pentagastrin acid output when compared to omeprazole. Esomeprazole when given orally at a lower dose achieves a similar gastric control than intravenous esomeprazole. The gastric pH with a high dose esomeprazole when given either orally or intravenously has not been measured among Hong Kong Chinese. If a high dose oral esomeprazole achieves a similar pH control near gastric neutrality, the oral regime can be used in place of the intravenous formulation. This represents significant convenience in dosing and cost savings.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Intravenous bolus injection of esomeprazole | 80mg followed by continuous intravenous infusion of 8mg per hour for 24 hours |
| DRUG | Oral esomeprazole | 40mg every 12 hours for 24 hours |
Timeline
- Start date
- 2004-07-01
- Primary completion
- 2011-01-01
- Completion
- 2011-01-01
- First posted
- 2005-09-14
- Last updated
- 2012-08-28
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT00164788. Inclusion in this directory is not an endorsement.